Skip to main content
NIPH logo

Mapping of drugs and cancer

Project

|

Last update

This large-scale, registry-based project will investigate whether drugs are associated with cancer incidence. The project will also develop a statistical tool for monitoring prescription drugs with regard to cancer risk.

Background

Several studies have shown that there may be a link between some prescription drugs and cancer risk. However, because of the long follow-up time required to identify these associations, it is difficult to study this with traditional pharmaepidemiological methods. The aim of this project is to investigate all combinations of drugs and cancers, and look at both cancer incidence and cancer survival. 

Study design and data material

The data material in this study mainly consists of data from the Norwegian Prescription Database and the Cancer Registry. The data material will consist of approximately 200 000 cancer cases from 2007-2015. Additional data are retrieved from Statistics Norway, the Medical Birth Registry and the Norwegian Patient Registry (see figure below).

Read more about the Cancer Registry's research on medicines.

About the project

REK: The project is approved in REK, Ref. no. 2016/352

 

Published |Last update